ad image
CDMO Market Insight, Pricing and Benchmarking Reports
NICE INSIGHT REPORT

Messenger Ribonucleic Acid, mRNA:Market Insight, CDMO Pricing and Competitor Benchmarking

Updated Monthly
  • 2025 CDMO pricing data for 39 clinical and commercial mRNA development and manufacturing RFP service line items

  • Exhaustive directory of capabilities profiles for the top 75 CDMOs specializing in mRNA development and manufacturing

  • Technical focus on mRNA stability, scaling, processing, and purification technologies

  • Includes Nice Insight's Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming mRNA-based trials, sourced from the FDA Clinical Trials Database

Key market insights for innovators, CDMOs, and investors in the mRNA industry. Mix and match subscriptions to fit your organization's goals.

Trends & Opinions

Trends & Opinions

Immediate access to Nice Insight's mRNA Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.

Clinical Trials Landscape

Clinical Trials Landscape

Access to Nice Insight's mRNA Clinical Trials report, plus access to our multi-modality Clinical Trial Landscape tool — an in-depth, interactive study of current and upcoming mRNA trials.

CDMO Pricing

CDMO Pricing

Access to Nice Insight's mRNA CDMO Pricing Data, including price breakdowns for over 35 distinct outsourcing RFP service line items.

CDMO Profiles & Capacity

CDMO Profiles & Capacity

Access to Nice Insight's mRNA CDMO Directory, including capabilities for more than 70 mRNA outsourcing organizations across North America, Europe, and Asia.

Our Market Insight provides preclinical-through-commercial research, data and analysis from Ph.D. scientists and respected voices in biopharma.

Master the mRNA Market, Preclinical through Commercial:

/hubfs/2024%20Reports/03_mRNA/01%20pricing%20data%20icon%2065x65@2x.png

Competitive Benchmarking

/hubfs/2024%20Reports/03_mRNA/02%20profiles%20icon%2065x65@2x.png

70+ mRNA CDMO Profiles

/hubfs/2024%20Reports/03_mRNA/03%20pie%20chart%20icon%2065x65@2x.png

Clinical Trial Analysis

/hubfs/2024%20Reports/03_mRNA/04%20pipeline%20icon%2065x65@2x.png

Biotech Funding Trends

/hubfs/2024%20Reports/03_mRNA/05%20data%20analytics%20icon%2065x65@2x.png

Market Growth Projections

/hubfs/2024%20Reports/03_mRNA/06%20benefits%20icon%2065x65@2x.png

Manufacturing Challenges & Innovations

Over 900 hours of data collection and analysis

with invaluable insights from industry experts